Acrobiosystems Co.,Ltd. (SHE:301080)
41.41
+1.28 (3.19%)
At close: Jun 23, 2026
Acrobiosystems Revenue
Acrobiosystems had revenue of 235.59M CNY in the quarter ending March 31, 2026, with 26.33% growth. This brings the company's revenue in the last twelve months to 887.21M, up 29.42% year-over-year. In the year 2025, Acrobiosystems had annual revenue of 838.12M with 29.94% growth.
Revenue (ttm)
887.21M
Revenue Growth
+29.42%
P/S Ratio
7.56
Revenue / Employee
958.11K
Employees
926
Market Cap
6.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 838.12M | 193.10M | 29.94% |
| Dec 31, 2024 | 645.02M | 101.37M | 18.65% |
| Dec 31, 2023 | 543.65M | 69.22M | 14.59% |
| Jan 1, 2023 | 474.43M | 89.44M | 23.23% |
| Jan 1, 2022 | 384.99M | 138.67M | 56.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Youcare Pharmaceutical Group | 2.42B |
| Xiangxue Pharmaceutical | 1.53B |
| Chengdu Easton Biopharmaceuticals | 1.35B |
| Shanghai Medicilon | 1.26B |
| Chengdu Kanghua Biological Products | 1.20B |
| Bio-Thera Solutions | 980.25M |
| GemPharmatech | 830.61M |
| Zhejiang Ausun Pharmaceutical | 794.80M |